Jianmin Pharmaceutical Group Co.,Ltd.

Informe acción SHSE:600976

Capitalización de mercado: CN¥6.7b

Salud financiera de hoja de balance de Jianmin Pharmaceutical GroupLtd

Salud financiera controles de criterios 5/6

Jianmin Pharmaceutical GroupLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥150.9M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥4.2B and CN¥1.8B respectively. Jianmin Pharmaceutical GroupLtd's EBIT is CN¥164.3M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥1.1B.

Información clave

6.3%

Ratio deuda-patrimonio

CN¥150.89m

Deuda

Ratio de cobertura de intereses-0.7x
EfectivoCN¥1.06b
PatrimonioCN¥2.41b
Total pasivoCN¥1.80b
Activos totalesCN¥4.21b

Actualizaciones recientes sobre salud financiera

Recent updates

If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Sep 25
If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

Aug 25
Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

Jul 12
The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

Jun 30
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

May 21
We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Apr 26
We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Análisis de la situación financiera

Pasivos a corto plazo: 600976's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.7B).

Pasivo a largo plazo: 600976's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥80.6M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 600976 has more cash than its total debt.

Reducción de la deuda: 600976's debt to equity ratio has increased from 0% to 6.3% over the past 5 years.

Cobertura de la deuda: 600976's debt is well covered by operating cash flow (136.7%).

Cobertura de intereses: 600976 earns more interest than it pays, so coverage of interest payments is not a concern.


Hoja de balance


Descubre empresas con salud financiera